Nadia Zaffaroni

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 37

Top Venues

International journal of molecular sciences

Cancer discovery

Cancers

Cells

Fondazione IRCCS Istituto Nazionale dei Tumori

Università degli Studi di Milano (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fondazione IRCCS Istituto Nazionale dei Tumori

Italy

Head of Research Unit (Molecular Pharmacology)

Fondazione IRCCS Istituto Nazionale dei Tumori

Italy

Deputy Director Institutional Programme on "Prostate Cancer"

Fondazione IRCCS Istituto Nazionale dei Tumori

Italy

Team Leader

Fondazione IRCCS Istituto Nazionale dei Tumori

Italy

Investigator

Fondazione IRCCS Istituto Nazionale dei Tumori

Italy

Associate Researcher

Institute for Cancer Research,The Norwegian Radium Hospital

Norway

Guest Scientist

Education History

Università degli Studi di Milano

Italy

PHD

Publications

Silvia Stacchiotti, Silvia Martini, Sandro Pasquali, Anna Maria Frezza, Alessia Beretta, Stefano Percio, Mara Lecchi, Monica Tortoreto, Marta Barisella, Paola Collini, Gian Paolo Dagrada, Alessandra Merlini, Paul H Huang, Andrew Jenks, Robin L Jones, William D Tap, Matilde Ingrosso, Carlo Morosi, Silvia Brich, Claudia Giani, Paolo Verderio, Paolo Giovanni Casali, Hugh Leonard, Alessandro Gronchi, Valentina Zuco, Nadia Zaffaroni
GDF-15 predicts epithelioid hemangioendothelioma aggressiveness and is down-regulated by sirolimus through ATF4/ATF5 suppression. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Yaniv Kazansky, Daniel Cameron, Helen S Mueller, Phillip Demarest, Nadia Zaffaroni, Noemi Arrighetti, Valentina Zuco, Yasumichi Kuwahara, Romel Somwar, Marc Ladanyi, Rui Qu, Elisa De Stanchina, Filemon Dela Cruz, Andrew L Kung, Mrinal M Gounder, Alex Kentsis
Overcoming Clinical Resistance to EZH2 Inhibition Using Rational Epigenetic Combination Therapy. Cancer discovery 14 (6) (2024)
Yaniv Kazansky, Daniel Cameron, Helen S Mueller, Phillip Demarest, Nadia Zaffaroni, Noemi Arrighetti, Valentina Zuco, Yasumichi Kuwahara, Romel Somwar, Marc Ladanyi, Rui Qu, Elisa De Stanchina, Filemon Dela Cruz, Andrew L Kung, Mrinal M Gounder, Alex Kentsis
Overcoming Clinical Resistance to EZH2 Inhibition Using Rational Epigenetic Combination Therapy. Cancer discovery 14 (6) (2024)
Yaniv Kazansky, Daniel Cameron, Helen S Mueller, Phillip Demarest, Nadia Zaffaroni, Noemi Arrighetti, Valentina Zuco, Yasumichi Kuwahara, Romel Somwar, Marc Ladanyi, Rui Qu, Elisa De Stanchina, Filemon Dela Cruz, Andrew L Kung, Mrinal M Gounder, Alex Kentsis
Overcoming clinical resistance to EZH2 inhibition using rational epigenetic combination therapy. Cancer discovery (2024)
Yaniv Kazansky, Daniel Cameron, Helen S Mueller, Phillip Demarest, Nadia Zaffaroni, Noemi Arrighetti, Valentina Zuco, Yasumichi Kuwahara, Romel Somwar, Marc Ladanyi, Rui Qu, Elisa De Stanchina, Filemon Dela Cruz, Andrew L Kung, Mrinal M Gounder, Alex Kentsis
Overcoming Clinical Resistance to EZH2 Inhibition Using Rational Epigenetic Combination Therapy. Cancer discovery 14 (6) (2024)
Yaniv Kazansky, Daniel Cameron, Helen S Mueller, Phillip Demarest, Nadia Zaffaroni, Noemi Arrighetti, Valentina Zuco, Yasumichi Kuwahara, Romel Somwar, Marc Ladanyi, Rui Qu, Elisa De Stanchina, Filemon Dela Cruz, Andrew L Kung, Mrinal M Gounder, Alex Kentsis
Overcoming clinical resistance to EZH2 inhibition using rational epigenetic combination therapy. Cancer discovery (2024)
Yaniv Kazansky, Daniel Cameron, Helen S Mueller, Phillip Demarest, Nadia Zaffaroni, Noemi Arrighetti, Valentina Zuco, Yasumichi Kuwahara, Romel Somwar, Marc Ladanyi, Rui Qu, Elisa De Stanchina, Filemon Dela Cruz, Andrew L Kung, Mrinal M Gounder, Alex Kentsis
Overcoming Clinical Resistance to EZH2 Inhibition Using Rational Epigenetic Combination Therapy. Cancer discovery 14 (6) (2024)
Yaniv Kazansky, Daniel Cameron, Helen S Mueller, Phillip Demarest, Nadia Zaffaroni, Noemi Arrighetti, Valentina Zuco, Yasumichi Kuwahara, Romel Somwar, Marc Ladanyi, Rui Qu, Elisa De Stanchina, Filemon Dela Cruz, Andrew L Kung, Mrinal M Gounder, Alex Kentsis
Overcoming clinical resistance to EZH2 inhibition using rational epigenetic combination therapy. Cancer discovery (2024)
Yaniv Kazansky, Daniel Cameron, Helen S Mueller, Phillip Demarest, Nadia Zaffaroni, Noemi Arrighetti, Valentina Zuco, Yasumichi Kuwahara, Romel Somwar, Marc Ladanyi, Rui Qu, Elisa De Stanchina, Filemon Dela Cruz, Andrew L Kung, Mrinal M Gounder, Alex Kentsis
Overcoming Clinical Resistance to EZH2 Inhibition Using Rational Epigenetic Combination Therapy. Cancer discovery 14 (6) (2024)
Nadia Zaffaroni, Giovanni Luca Beretta
The Therapeutic Potential of Pyroptosis in Melanoma. International journal of molecular sciences 24 (2) (2023)
Valentina Zuco, Sandro Pasquali, Monica Tortoreto, Stefano Percio, Valentina Doldi, Marta Barisella, Paola Collini, Gian Paolo Dagrada, Silvia Brich, Patrizia Gasparini, Marco Fiore, Michela Casanova, Anna Maria Frezza, Alessandro Gronchi, Silvia Stacchiotti, Andrea C Ferrari, Nadia Zaffaroni
Effectiveness of irinotecan plus trabectedin in a desmoplastic small round cell tumor patient-derived xenograft. Disease models & mechanisms (2023)
Marika A Frańczak, Oliwia Król, Gabriela Harasim, Agata Jędrzejewska, Nadia Zaffaroni, Carlotta Granchi, Filippo Minutolo, Soodabeh Shahidsales, Elisa Giovannetti, Ryszard Tomasz Smolenski, Godefridus J Peters
Metabolic Effects of New Glucose Transporter (GLUT-1) and Lactate Dehydrogenase-A (LDH-A) Inhibitors against Chemoresistant Malignant Mesothelioma. International journal of molecular sciences 24 (9) (2023)
Marika A Frańczak, Oliwia Król, Gabriela Harasim, Agata Jędrzejewska, Nadia Zaffaroni, Carlotta Granchi, Filippo Minutolo, Soodabeh Shahidsales, Elisa Giovannetti, Ryszard Tomasz Smolenski, Godefridus J Peters
Metabolic Effects of New Glucose Transporter (GLUT-1) and Lactate Dehydrogenase-A (LDH-A) Inhibitors against Chemoresistant Malignant Mesothelioma. International journal of molecular sciences 24 (9) (2023)
Nadia Zaffaroni, Giovanni Luca Beretta
The Therapeutic Potential of Pyroptosis in Melanoma. International journal of molecular sciences 24 (2) (2023)
Silvia Gobbi, Silvia Martini, Riccardo Rozza, Angelo Spinello, Jessica Caciolla, Angela Rampa, Federica Belluti, Nadia Zaffaroni, Alessandra Magistrato, Alessandra Bisi
Switching from Aromatase Inhibitors to Dual Targeting Flavonoid-Based Compounds for Breast Cancer Treatment. Molecules (Basel, Switzerland) 28 (7) (2023)
Salvatore Princiotto, Maria Karelou, Rachel Ioannidi, Giovanni Luca Beretta, Nadia Zaffaroni, Roberto Artali, Ioannis K Kostakis, Stefania Mazzini, Sabrina Dallavalle
Exploring the Interaction of New Pyridoquinazoline Derivatives with G-Quadruplex in the c-MYC Promoter Region. International journal of molecular sciences 24 (18) (2023)
Nadia Zaffaroni, Giovanni Luca Beretta
The Therapeutic Potential of Pyroptosis in Melanoma. International journal of molecular sciences 24 (2) (2023)
Natalia Maciejewska, Mateusz Olszewski, Jakub Jurasz, Maciej Baginski, Maryna Stasevych, Viktor Zvarych, Marco Folini, Nadia Zaffaroni
Teloxantron inhibits the processivity of telomerase with preferential DNA damage on telomeres. Cell death & disease 13 (11) (2022)
Giovanni Luca Beretta, Nadia Zaffaroni
Necroptosis and Prostate Cancer: Molecular Mechanisms and Therapeutic Potential. Cells 11 (7) (2022)
Sukhvir Kaur Bhangu, Soraia Fernandes, Giovanni Luca Beretta, Stella Tinelli, Marco Cassani, Agata Radziwon, Marcin Wojnilowicz, Sophia Sarpaki, Irinaios Pilatis, Nadia Zaffaroni, Giancarlo Forte, Frank Caruso, Muthupandian Ashokkumar, Francesca Cavalieri
Transforming the Chemical Structure and Bio-Nano Activity of Doxorubicin by Ultrasound for Selective Killing of Cancer Cells. Advanced materials (Deerfield Beach, Fla.) 34 (13) (2022)
Valentina Doldi, Mara Lecchi, Silva Ljevar, Maurizio Colecchia, Elisa Campi, Giovanni Centonze, Cristina Marenghi, Tiziana Rancati, Rosalba Miceli, Paolo Verderio, Riccardo Valdagni, Paolo Gandellini, Nadia Zaffaroni
Potential of the Stromal Matricellular Protein Periostin as a Biomarker to Improve Risk Assessment in Prostate Cancer. International journal of molecular sciences 23 (14) (2022)
Rihan El Bezawy, Stefano Percio, Chiara Maura Ciniselli, Michelandrea De Cesare, Gennaro Colella, Matteo Dugo, Silvia Veneroni, Valentina Doldi, Silvia Martini, Dario Baratti, Shigeki Kusamura, Paolo Verderio, Marcello Deraco, Paolo Gandellini, Nadia Zaffaroni, Valentina Zuco
miR-550a-3p is a prognostic biomarker and exerts tumor-suppressive functions by targeting HSP90AA1 in diffuse malignant peritoneal mesothelioma. Cancer gene therapy 29 (10) (2022)
Irene Alessandrini, Stefano Percio, Eisa Naghshineh, Valentina Zuco, Silvia Stacchiotti, Alessandro Gronchi, Sandro Pasquali, Nadia Zaffaroni, Marco Folini
Telomere as a Therapeutic Target in Dedifferentiated Liposarcoma. Cancers 14 (11) (2022)
Chiara Platella, Stefania Mazzini, Ettore Napolitano, Luce M Mattio, Giovanni Luca Beretta, Nadia Zaffaroni, Andrea Pinto, Daniela Montesarchio, Sabrina Dallavalle
Plant-Derived Stilbenoids as DNA-Binding Agents: From Monomers to Dimers. Chemistry (Weinheim an der Bergstrasse, Germany) 27 (34) (2021)
Andrew Chin, Javier Mariscal, Minhyung Kim, Giorgia Guerra, Blandine Victor, Chen Qian, Elisabetta Broseghini, Edwin Posadas, Michael R Freeman, Shivani Sharma, Paolo Gandellini, Nadia Zaffaroni, Sungyong You, Keith Syson Chan, Jlenia Guarnerio, Muller Fabbri, Dolores Di Vizio
miR-1227 Targets SEC23A to Regulate the Shedding of Large Extracellular Vesicles. Cancers 13 (22) (2021)
Valentina Doldi, Rihan El Bezawy, Nadia Zaffaroni
MicroRNAs as Epigenetic Determinants of Treatment Response and Potential Therapeutic Targets in Prostate Cancer. Cancers 13 (10) (2021)
Nadia Zaffaroni, Giovanni Luca Beretta
Nanoparticles for Ferroptosis Therapy in Cancer. Pharmaceutics 13 (11) (2021)
Paolo Gandellini, Chiara Maura Ciniselli, Tiziana Rancati, Cristina Marenghi, Valentina Doldi, Rihan El Bezawy, Mara Lecchi, Melanie Claps, Mario Catanzaro, Barbara Avuzzi, Elisa Campi, Maurizio Colecchia, Fabio Badenchini, Paolo Verderio, Riccardo Valdagni, Nadia Zaffaroni
Prediction of Grade Reclassification of Prostate Cancer Patients on Active Surveillance through the Combination of a Three-miRNA Signature and Selected Clinical Variables. Cancers 13 (10) (2021)
Irene Alessandrini, Marta Recagni, Nadia Zaffaroni, Marco Folini
On the Road to Fight Cancer: The Potential of G-quadruplex Ligands as Novel Therapeutic Agents. International journal of molecular sciences 22 (11) (2021)
Silvia Martini, Valentina Zuco, Monica Tortoreto, Stefano Percio, Elisa Campi, Rihan El Bezawy, Valentina Doldi, Yosef Landesman, Marzia Pennati, Nadia Zaffaroni
miR-34a-Mediated Survivin Inhibition Improves the Antitumor Activity of Selinexor in Triple-Negative Breast Cancer. Pharmaceuticals (Basel, Switzerland) 14 (6) (2021)
Marta Recagni, Joanna Bidzinska, Nadia Zaffaroni, Marco Folini
The Role of Alternative Lengthening of Telomeres Mechanism in Cancer: Translational and Therapeutic Implications. Cancers 12 (4) (2020)
Rihan El Bezawy, Martina Tripari, Stefano Percio, Alessandro Cicchetti, Monica Tortoreto, Claudio Stucchi, Stella Tinelli, Valentina Zuco, Valentina Doldi, Paolo Gandellini, Riccardo Valdagni, Nadia Zaffaroni
SPOP Deregulation Improves the Radiation Response of Prostate Cancer Models by Impairing DNA Damage Repair. Cancers 12 (6) (2020)
Federica Rotundo, Denis Cominetti, Rihan El Bezawy, Stefano Percio, Valentina Doldi, Monica Tortoreto, Valentina Zuco, Riccardo Valdagni, Nadia Zaffaroni, Paolo Gandellini
miR-1272 Exerts Tumor-Suppressive Functions in Prostate Cancer via HIP1 Suppression. Cells 9 (2) (2020)
Silvia Martini, Mariangela Figini, Aurora Croce, Barbara Frigerio, Marzia Pennati, Alessandro Massimo Gianni, Cinzia De Marco, Maria Grazia Daidone, Christian Argueta, Yosef Landesman, Nadia Zaffaroni, Alessandro Satta
Selinexor Sensitizes TRAIL-R2-Positive TNBC Cells to the Activity of TRAIL-R2xCD3 Bispecific Antibody. Cells 9 (10) (2020)
Giorgia Catinella, Luce Micaela Mattio, Loana Musso, Stefania Arioli, Diego Mora, Giovanni Luca Beretta, Nadia Zaffaroni, Andrea Pinto, Sabrina Dallavalle
Structural Requirements of Benzofuran Derivatives Dehydro-δ- and Dehydro-ε-Viniferin for Antimicrobial Activity Against the Foodborne Pathogen Listeria monocytogenes. International journal of molecular sciences 21 (6) (2020)
Valentina Profumo, Barbara Forte, Stefano Percio, Federica Rotundo, Valentina Doldi, Elena Ferrari, Nicola Fenderico, Matteo Dugo, Dario Romagnoli, Matteo Benelli, Riccardo Valdagni, Diletta Dolfini, Nadia Zaffaroni, Paolo Gandellini
LEADeR role of miR-205 host gene as long noncoding RNA in prostate basal cell differentiation. Nature communications 10 (1) (2019)
Anna Rossini, Franco Zunino, Giusi Ruggiero, Michelandrea De Cesare, Denis Cominetti, Monica Tortoreto, Cinzia Lanzi, Giuliana Cassinelli, Roberta Zappasodi, Claudio Tripodo, Alessandro Gulino, Nadia Zaffaroni, Massimo Di Nicola
Microenvironment modulation and enhancement of antilymphoma therapy by the heparanase inhibitor roneparstat. Hematological oncology 36 (1) (2017)

Nadia Zaffaroni.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Nadia Zaffaroni